Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli

Infection and Immunity

Volumn 71, Issue 9, 2003, Pages 5149-5155

  Ochoa, Theresa J ^a   Noguera Obenza, Marita ^a   Ebel, Frank ^b   Guzman, Carlos A ^c   Gomez, Henry F ^a   Cleary, Thomas G ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; LACTOFERRIN;

ACTIN POLYMERIZATION; ARTICLE; BACTERIUM ADHERENCE; CELL PROTECTION; CONTROLLED STUDY; ESCHERICHIA COLI; HEMOLYSIS; HEP 2 CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION;

ACTINS; BACTERIAL ADHESION; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CELL LINE; DIARRHEA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HEMOLYSIS; HUMANS; INFANT; LACTOFERRIN; RECOMBINANT PROTEINS;

EID: 0041823407     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.9.5149-5155.2003     Document Type: Article

References (62)

1. Abe, A., U. Heczko, R. G. Hegele, and B. B. Finlay. 1998. Two enteropathogenic Escherichia coli type III secreted proteins, EspA and EspB, are virulence factors. J. Exp. Med. 188:1907-1916.
2. Appelmelk, B. J., Y. Q. An, M. Geerts, B. G. Thijs, H. A. de Boer, D. M. MacLaren, J. de Graaff, and J. H. Nuijens. 1994. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62:2628-2632.
3. Arnold, R. R., M. F. Cole, and J. R. McGhee. 1977. A bactericidal effect for human lactoferrin. Science 197:263-265.
4. Blake, P. A., S. Ramos, K. L. MacDonald, V. Rassi, T. A. Gomes, C. Ivey, N. H. Bean, and L. R. Trabulsi. 1993. Pathogen-specific risk factors and protective factors for acute diarrheal disease in urban Brazilian infants. J. Infect. Dis. 167:627-632.
5. Brandenburg, K., G. Jurgens, M. Muller, S. Fukuoka, and M. H. Koch. 2001. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol. Chem. 382:1215-1225.
6. Brock, J. H. 2002. The physiology of lactoferrin. Biochem. Cell Biol. 80:1-6.
7. Camara, L. M., S. B. Carbonare, M. L. Silva, and M. M. Carneiro-Sampaio. 1994. Inhibition of enteropathogenic Escherichia coli (EPEC) adhesion to HeLa cells by human colostrum: detection of specific sIgA related to EPEC outer-membrane proteins. Int. Arch. Allergy Immunol. 103:307-310.
8. Collington, G. K., I. W. Booth, M. S. Donnenberg, J. B. Kaper, and S. Knutton. 1998. Enteropathogenic Escherichia coli virulence genes encoding secreted signaling proteins are essential for modulation of Caco-2 cell electrolyte transport. Infect. Immun. 66:6049-6053.
9. Cravioto, A., A. Tello, H. Villafan, J. Ruiz, S. del Vedovo, and J. R. Neeser. 1991. Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J. Infect. Dis. 163:1247-1255.
10. Daniell, S. J., N. Takahashi, R. Wilson, D. Friedberg, I. Rosenshine, F. P. Booy, R. K. Shaw, S. Knutton, G. Frankel, and S. Aizawa. 2001. The filamentous type III secretion translocon of enteropathogenic Escherichia coli. Cell. Microbiol. 3:865-871.
11. de Araujo, A. N., and L. G. Giugliano. 2001. Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to HeLa cells. BMC Microbiol. 1:25.
12. Delahay, R. M., S. Knutton, R. K. Shaw, E. L. Hartland, M. J. Pallen, and G. Frankel. 1999. The coiled-coil domain of EspA is essential for the assembly of the type III secretion translocon on the surface of enteropathogenic Escherichia coli. J. Biol. Chem. 274:35969-35974.
13. Delneri, M. T., S. B. Carbonare, M. L. Silva, P. Palmeira, and M. M. Carneiro-Sampaio. 1997. Inhibition of enteropathogenic Escherichia coli adhesion to HEp-2 cells by colostrum and milk from mothers delivering low-birth-weight neonates. Eur. J. Pediatr. 156:493-498.
14. DeVinney, R., A. Gauthier, A. Abe, and B. B. Finlay. 1999. Enteropathogenic Escherichia coli: a pathogen that inserts its own receptor into host cells. Cell. Mol. Life Sci. 55:961-976.
15. Ebel, F., C. Deibel, A. U. Kresse, C. A. Guzman, and T. Chakraborty. 1996. Temperature- and medium-dependent secretion of proteins by Shiga toxin-producing Escherichia coli. Infect. Immun. 64:4472-4479.
16. Ebel, F., T. Podzadel, M. Rohde, A. U. Kresse, S. Kramer, C. Deibel, C. A. Guzman, and T. Chakraborty. 1998. Initial binding of Shiga toxin-producing Escherichia coli to host cells and subsequent induction of actin rearrangements depend on filamentous EspA-containing surface appendages. Mol. Microbiol. 30:147-161.
17. Edde, L., R. B. Hipolito, F. F. Hwang, D. R. Headon, R. A. Shalwitz, and M. P. Sherman. 2001. Lactoferrin protects neonatal rats from gut-related systemic infection. Am. J. Physiol. Gastrointest. Liver Physiol. 281:G1140-G1150.
18. Elass-Rochard, E., A. Roseanu, D. Legrand, M. Trif, V. Salmon, C. Motas, J. Montreuil, and G. Spik. 1995. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J. 312:839-845.
19. Foubister, V., I. Rosenshine, M. S. Donnenberg, and B. B. Finlay. 1994. The eaeB gene of enteropathogenic Escherichia coli is necessary for signal transduction in epithelial cells. Infect. Immun. 62:3038-3040.
20. Frankel, G., A. D. Phillips, I. Rosenshine, G. Dougan, J. B. Kaper, and S. Knutton. 1998. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30:911-921.
21. Gomez, H., T. Ochoa, L. Carlin, and T. Cleary. 2003. Human lactoferrin impairs virulence of Shigella flexneri. J. Infect. Dis. 187:87-95.
22. Gomez, H., T. Ochoa, I. Herrera-Insua, L. Carlin, and T. Cleary. 2002. Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis. Infect. Immun. 70:7050-7053.
23. Gomez, H. F., I. Herrera-Insua, M. M. Siddiqui, V. A. Diaz-Gonzalez, E. Caceres, D. S. Newburg, and T. G. Cleary. 2001. Protective role of human lactoferrin against invasion of Shigella flexneri M90T. Adv. Exp. Med. Biol. 501:457-467.
24. Goosney, D. L, D. G. Knoechel, and B. B. Finlay. 1999. Enteropathogenic E. coli, Salmonella, and Shigella: masters of host cell cytoskeletal exploitation. Emerg. Infect. Dis. 5:216-223.
25. Hanson, L. A. 1999. Human milk and host defense: immediate and long-term effects. Acta Paediatr. Suppl. 88:42-46.
26. Hanson, L. A., F. Jalil, R. Ashraf, S. Bernini, B. Carlsson, J. R. Cruz, T. Gonzalez, M. Hahn-Zoric, L. Mellander, Y. Minoli, et al. 1991. Characteristics of human milk antibodies and their effect in relation to the epidemiology of breastfeeding and infections in a developing country. Adv. Exp. Med. Biol. 310:1-15.
27. Hartland, E. L., S. J. Daniell, R. M. Delahay, B. C. Neves, T. Wallis, R. K. Shaw, C. Hale, S. Knutton, and G. Frankel. 2000. The type III protein translocation system of enteropathogenic Escherichia coli involves EspA-EspB protein interactions. Mol. Microbiol. 35:1483-1492.
28. Hendrixson, D. R., J. Qiu, S. C. Shewry, D. L. Fink, S. Petty, E. N. Baker, A. G. Plaut, and J. W. St. Geme III. 2003. Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites. Mol. Microbiol. 47:607-617.
29. Ide, T., S. Laarmann, L. Greune, H. Schillers, H. Oberleithner, and M. A. Schmidt. 2001. Characterization of translocation pores inserted into plasma membranes by type III-secreted Esp proteins of enteropathogenic Escherichia coli. Cell. Microbiol. 3:669-679.
30. Jarvis, K. G., J. A. Giron, A. E. Jerse, T. K. McDaniel, M. S. Donnenberg, and J. B. Kaper. 1995. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc. Natl. Acad. Sci. USA 92:7996-8000.
31. Kenny, B., A. Abe, M. Stein, and B. B. Finlay. 1997. Enteropathogenic Escherichia coli protein secretion is induced in response to conditions similar to those in the gastrointestinal tract. Infect. Immun. 65:2606-2612.
32. Kenny, B., R. DeVinney, M. Stein, D. J. Reinscheid, E. A. Frey, and B. B. Finlay. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520.
33. Knutton, S., I. Rosenshine, M. J. Pallen, I. Nisan, B. C. Neves, C. Bain, C. Wolff, G. Dougan, and G. Frankel. 1998. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J. 17:2166-2176.
34. Kruzel, M. L., Y. Harari, D. Mailman, J. K. Actor, and M. Zimecki. 2002. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin. Exp. Immunol. 130:25-31.
35. Lee, W. J., J. L. Farmer, M. Hilty, and Y. B. Kim. 1998. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect. Immun. 66:1421-1426.
36. Loureiro, I., G. Frankel, J. Adu-Bobie, G. Dougan, L. R. Trabulsi, and M. M. Carneiro-Sampaio. 1998. Human colostrum contains IgA antibodies reactive to enteropathogenic Escherichia coli virulence-associated proteins: intimin, BfpA, EspA, and EspB. J. Pediatr. Gastroenterol. Nutr. 27:166-171.
37. Manjarrez-Hernandez, H. A., S. Gavilanes-Parra, E. Chavez-Berrocal, A. Navarro-Ocana, and A. Cravioto. 2000. Antigen detection in enteropathogenic Escherichia coli using secretory immunoglobulin A antibodies isolated from human breast milk. Infect. Immun. 68:5030-5036.
38. Martinez, M. B., C. R. Taddei, A. Ruiz-Tagle, L. R. Trabulsi, and J. A. Giron. 1999. Antibody response of children with enteropathogenic Escherichia coli infection to the bundle-forming pilus and locus of enterocyte effacement-encoded virulence determinants. J. Infect. Dis. 179:269-274.
39. Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
40. Newman, J. V., B. A. Zabel, S. S. Jha, and D. B. Schauer. 1999. Citrobacter rodentium espB is necessary for signal transduction and for infection of laboratory mice. Infect. Immun. 67:6019-6025.
41. Noguera-Obenza, M., T. J. Ochoa, H. F. Gomez, M. L. Guerrero, I. Herrera-Insua, A. L. Morrow, G. Ruiz-Palacios, L. K. Pickering, C. A. Guzman, and T. G. Cleary. 2003, Human milk secretory antibodies against attaching and effacing Escherichia coli antigens. Emerg. Infect. Dis. 9:545-551.
42. Parissi-Crivelli, A., J. M. Parissi-Crivelli, and J. A. Giron. 2000. Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies. J. Clin. Microbiol. 38:2696-2700.
43. Plaut, A. G., J. Qiu, and J. W. St. Geme III. 2000. Human lactoferrin proteolytic activity: analysis of the cleaved region in the IgA protease of Haemophilus influenzae. Vaccine 19(Suppl. 1):S148-S152.
44. Qiu, J., D. R. Hendrixson, E. N. Baker, T. F. Murphy, J. W. St. Geme III, and A. G. Plaut. 1998. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc. Natl. Acad. Sci. USA 95:12641-12646.
45. Sanches, M. I., R. Keller, E. L. Hartland, D. M. Figueiredo, M. Batchelor, M. B. Martinez, G. Dougan, M. M. Careiro-Sampaio, G. Frankel, and L. R. Trabulsi. 2000. Human colostrum and serum contain antibodies reactive to the intimin-binding region of the enteropathogenic Escherichia coli translocated intimin receptor. J. Pediatr. Gastroenterol. Nutr. 30:73-77.
46. Savkovic, S. D., A. Koutsouris, and G. Hecht. 1997. Activation of NF-κB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am. J. Physiol. 273:C1160-C1167.
47. Savkovic, S. D., A. Koutsouris, and G. Hecht. 1996. Attachment of a noninvasive enteric pathogen, enteropathogenic Escherichia coli, to cultured human intestinal epithelial monolayers induces transmigration of neutrophils. Infect. Immun. 64:4480-4487.
48. Sekiya, K., M. Ohishi, T. Ogino, K. Tamano, C. Sasakawa, and A. Abe. 2001. Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc. Natl. Acad. Sci. USA 98:11638-11643.
49. Shaw, R. K., S. Daniell, F. Ebel, G. Frankel, and S. Knutton. 2001. EspA filament-mediated protein translocation into red blood cells. Cell. Microbiol. 3:213-222.
50. Stein, M. A., D. A. Mathers, H. Yan, K. G. Baimbridge, and B. B. Finlay. 1996. Enteropathogenic Escherichia coli markedly decreases the resting membrane potential of Caco-2 and HeLa human epithelial cells. Infect. Immun. 64:4820-4825.
51. Stuart, J., S. Norrell, and J. P. Harrington. 1984. Kinetic effect of human lactoferrin on the growth of Escherichia coli 0111. Int. J. Biochem. 16:1043-1047.
52. Tacket, C. O., M. B. Sztein, G. Losonsky, A. Abe, B. B. Finlay, B. P. McNamara, G. T. Fantry, S. P. James, J. P. Nataro, M. M. Levine, and M. S. Donnenberg. 2000. Role of EspB in experimental human enteropathogenic Escherichia coli infection. Infect. Immun. 68:3689-3695.
53. Vallance, B. A., and B. B. Finlay. 2000. Exploitation of host cells by enteropathogenic Escherichia coli. Proc. Natl. Acad. Sci. USA 97:8799-8806.
54. Victora, C. G., P. G. Smith, J. P. Vaughan, L. C. Nobre, C. Lombardi, A. M. Teixeira, S. C. Fuchs, L. B. Moreira, L. P. Gigante, and F. C. Barros. 1989. Infant feeding and deaths due to diarrhea. A case-control study. Am. J. Epidemiol. 129:1032-1041.
55. Visca, P., C. Dalmastri, D. Verzili, G. Antonini, E. Chiancone, and P. Valenti. 1990. Interaction of lactoferrin with Escherichia coli cells and correlation with antibacterial activity. Med. Microbiol. Immunol. 179:323-333.
56. Warawa, J., B. B. Finlay, and B. Kenny. 1999. Type III secretion-dependent hemolytic activity of enteropathogenic Escherichia coli. Infect. Immun. 67:5538-5540.
57. Ward, P. P., S. Uribe-Luna, and O. M. Conneely. 2002. Lactoferrin and host defense. Biochem. Cell Biol. 80:95-102.
58. Wilson, R. K., R. K. Shaw, S. Daniell, S. Knutton, and G. Frankel. 2001. Role of EscF, a putative needle complex protein, in the type III protein translocation system of enteropathogenic Escherichia coli. Cell. Microbiol. 3:753-762.
59. Yamauchi, K., M. Tomita, T. J. Giehl, and R. T. Ellison III. 1993. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 61:719-728.
60. Yuhan, R., A. Koutsouris, S. D. Savkovic, and G. Hecht. 1997. Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability. Gastroenterology 113:1873-1882.
61. Zagulski, T., P. Lipinski, A. Zagulska, S. Broniek, and Z. Jarzabek. 1989. Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol. 70:697-704.
62. Zhang, G. H., D. M. Mann, and C. M. Tsai. 1999. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect. Immun. 67:1353-1358.